Market Sensing
Dow senses the pulse of the times and reads the flow.
We sense customer needs and technology trends and are continuously learning so we can react appropriately.
Our motto
Death valley story
Death Valley, a national park in eastern California, has long been known for its seemingly dead appearance without a single blade of grass.
But something strange happened in 2004
Short-lived but heavy rains caused the salt flats and sand dunes in the valley to be carpeted in colorful blooms.
Locals started calling it the “superbloom” Death Valley wasn't actually dead. The seeds were just waiting for rain.
Likewise, market development requires insight into what customers’ “unmet needs” are and how these needs manifest themselves in the market.
Dow has been developing markets to contribute to improvement of customer’s
medical practices through providing a better solution for unmet needs in the market.
Newly introduced techology by Dow
2005
R-Mix
Highly improved
virus culture assay
2006
HLA-SBT
Firstly introduced
high resolution
HLA assay
2009
Freelite
New technology
approved by NECA
2013
Sofia POCT
Influenza
New technology
approved by NECA
2015
B/T cell
rearrangement
New technology
approved by NECA
2016
CgA for NETs
New technology
approved by NECA
2020
HLA-NGS
Firstly introduced
high resolution
(NGS) HLA assay